Concepedia

Ticiana Leal

TL

Statistics

Publications

51

Citations

9.2K

H-Index

32

Active since

2011

Affiliations

University of Wisconsin Carbone Cancer Center(Current)

University of Wisconsin–Madison

Emory University

The University of Texas MD Anderson Cancer Center

Mirati Therapeutics (United States)

Ticiana Leal is an author at University of Wisconsin Carbone Cancer Center specializing in oncology, medicine, and non-small cell lung cancer treatment.

ORCID

Publications per year

2011–2024

51

Publications

51

Non–Small Cell Lung Cancer, Version 5.2017, NCCN Clinical Practice Guidelines in Oncology

David S. Ettinger, Douglas E. Wood, Dara L. Aisner et al. · Journal of the National Comprehensive Cancer Network · 2017 · 1.3K citations

, , +17

Five-Year Outcomes With Pembrolizumab Versus Chemotherapy for Metastatic Non–Small-Cell Lung Cancer With PD-L1 Tumor Proportion Score ≥ 50%

Martin Reck, Delvys Rodríguez‐Abreu, Andrew Robinson et al. · Journal of Clinical Oncology · 2021 · 1.1K citations · Full text

, , +17

NCCN Guidelines Insights: Non–Small Cell Lung Cancer, Version 2.2021

David S. Ettinger, Douglas E. Wood, Dara L. Aisner et al. · Journal of the National Comprehensive Cancer Network · 2021 · 1K citations · Full text

, , +17

NCCN Guidelines Insights: Non–Small Cell Lung Cancer, Version 1.2020

David S. Ettinger, Douglas E. Wood, Charu Aggarwal et al. · Journal of the National Comprehensive Cancer Network · 2019 · 1K citations · Full text

, , +12

Updated Overall Survival and PD-L1 Subgroup Analysis of Patients With Extensive-Stage Small-Cell Lung Cancer Treated With Atezolizumab, Carboplatin, and Etoposide (IMpower133)

Stephen V. Liu, Martin Reck, Aaron S. Mansfield et al. · Journal of Clinical Oncology · 2021 · 824 citations · Full text

, , +16

1–5 of 51